Literature DB >> 26414468

Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.

Eun-Young Karen Choi1, Barbara J McKenna.   

Abstract

Olmesartan is an antihypertensive medication belonging to the angiotensin II receptor blocker class of drugs that has recently been associated with severe enteropathy. Olmesartan-associated enteropathy is uncommon and may be difficult to recognize because of its clinical and histologic similarities to other clinical entities, including celiac sprue and autoimmune enteropathy. The purpose of this article is to review the clinical and histologic findings of olmesartan-associated enteropathy that have been reported in the literature and to discuss clinical entities to consider in the differential diagnosis of olmesartan-associated enteropathy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26414468     DOI: 10.5858/arpa.2015-0204-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  14 in total

Review 1.  Triple-combination therapy in the treatment of hypertension: a review of the evidence.

Authors:  R Düsing; B Waeber; M Destro; C Santos Maia; P Brunel
Journal:  J Hum Hypertens       Date:  2017-02-23       Impact factor: 3.012

2.  A Case of Sprue-like Enteropathy Associated With Valsartan and Irbesartan.

Authors:  Seo Yeon Yoo; Jihun Kim; Kee Wook Jung
Journal:  J Neurogastroenterol Motil       Date:  2022-04-30       Impact factor: 4.924

3.  Olmesartan-associated enteropathy.

Authors:  Vivian S Ebrahim; Jason Martin; Stacey Murthy; Elizabeth Odstrcil; He Huang; Daniel Polter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

Review 4.  Medication-associated gastrointestinal tract injury.

Authors:  Michael Vieth; Elizabeth Montgomery
Journal:  Virchows Arch       Date:  2017-01-30       Impact factor: 4.535

5.  Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge.

Authors:  Cláudio Martins; Cristina Teixeira; Suzane Ribeiro; Daniel Trabulo; Cláudia Cardoso; João Mangualde; Ricardo Freire; Ana Luísa Alves; Élia Gamito; Isabelle Cremers; Ana Paula Oliveira
Journal:  Case Rep Gastrointest Med       Date:  2016-10-10

6.  Olmesartan-induced enteropathy associated with cutaneous lesions.

Authors:  Nassim Hammoudi; Marie Dior; Vincent Giraud; Benoit Coffin
Journal:  Clin Case Rep       Date:  2016-03-02

7.  Telmisartan-induced sprue-like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers.

Authors:  Harshal Surendra Mandavdhare; Vishal Sharma; Kaushal K Prasad; Amit Kumar; Manish Rathi; Surinder S Rana
Journal:  Intest Res       Date:  2017-06-12

8.  Celiac-like Enteropathy Associated With Mycophenolate Sodium in Renal Transplant Recipients.

Authors:  Vassilis Filiopoulos; Stratigoula Sakellariou; Konstantinos Papaxoinis; Christina Melexopoulou; Smaragdi Marinaki; John N Boletis; Ioanna Delladetsima
Journal:  Transplant Direct       Date:  2018-07-20

9.  Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.

Authors:  Sripriya Gonakoti; Sanjiv Khullar; Aarthi Rajkumar
Journal:  Am J Case Rep       Date:  2019-01-26

Review 10.  Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan.

Authors:  Stefano Omboni; Massimo Volpe
Journal:  Cardiovasc Ther       Date:  2018-11-13       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.